Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leukoplakia × 5-aminolaevulinic acid-n-pentylester × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

5-aminolaevulinic acid-n-pentylester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01497951 2017-05-17

PDT

Medical University of Vienna

Phase 3 Completed

Leukoplakia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡